Ceria Nanoparticles as Copper Chaperones that Activate SOD1 for Synergistic Antioxidant Therapy to Treat Ischemic Vascular Diseases

Adv Mater. 2023 Apr;35(16):e2208989. doi: 10.1002/adma.202208989. Epub 2023 Mar 10.

Abstract

All exogenous nanomaterials undergo rapid biotransformation once injected into the body and fall short of executing the intended purpose. Here, it is reported that copper-deposited ceria nanoparticles (CuCe NPs) exhibit enhanced antioxidant effects over pristine ceria nanoparticles, as the released copper buffers the depletion of glutathione while providing the bioavailable copper as a cofactor for the antioxidant enzyme, superoxide dismutase 1. The upregulated intracellular antioxidants along with the ceria nanoparticles synergistically scavenge reactive oxygen species and promote anti-inflammation and M2 polarization of macrophages by modulating signal transducer and activator of transcription 1 and 6 (STAT1 and STAT6). The therapeutic effect of CuCe NPs is demonstrated in ischemic vascular diseases (i.e., murine models of hindlimb ischemia and myocardial infarction) in which the copper-deposition affords increased perfusion and alleviation in tissue damage. The results provide rationale that metal oxide nanomaterials can be designed in a way to induce the upregulation of specific biological factors for optimal therapeutic performance.

Keywords: anti-inflammation; antioxidants; nanozymes; oxidative stress; superoxide dismutase 1.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Copper
  • Humans
  • Ischemia
  • Mice
  • Nanoparticles*
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase-1 / metabolism
  • Superoxide Dismutase-1 / pharmacology
  • Vascular Diseases*

Substances

  • Antioxidants
  • Copper
  • Superoxide Dismutase-1
  • Reactive Oxygen Species
  • SOD1 protein, human